This year’s best-performing public company in Mass.? A 43-year-old biotech.


Massachusetts' biggest stock gainer as of October 2023 is a Waltham drugmaker that only just recently earned approval to market its first wholly-owned drug after more than four decades in business.

Previous Fenway Health workers officially unionize
Next Pelton, Chesloff: The moral and economic case for addressing health inequities